- Funding roundup: Megarounds for Strand and Minghui, plus SNIPR snags €35M FirstWord Pharma
- MIT Spinout Strand Therapeutics Raises $153 Million To Make Cancerous Tumors Light Up Forbes
- Big Pharmas back Strand’s $153M series B to advance mRNA drugs Fierce Biotech
- Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline Business Wire
- LG deepens bio push with US anticancer biotech The Korea Herald
Recent Comments